Breast cancer is a molecularly-heterogeneous disease and can be classified into four molecular subtypes, including luminal A, luminal B, human epidermal growth factor receptor type 2 (HER2) positive, and triple-negative breast cancer (TNBC)1,2. Here, ERBB2 is linked to breast carcinoma.